1. Field of the Invention
The present invention relates in certain embodiments to systems for treating vertebral compression fractures, and more particularly to a device and method for cutting a plane in a cancellous bone portion of a bone.
2. Description of the Related Art
Osteoporotic fractures are prevalent in the elderly, with an annual estimate of 1.5 million fractures in the United States alone. These include 750,000 vertebral compression fractures (VCFs) and 250,000 hip fractures. The annual cost of osteoporotic fractures in the United States has been estimated at $13.8 billion. The prevalence of VCFs in women age 50 and older has been estimated at 26%. The prevalence increases with age, reaching 40% among 80-year-old women. Medical advances aimed at slowing or arresting bone loss from aging have not provided solutions to this problem. Further, the population affected will grow steadily as life expectancy increases. Osteoporosis affects the entire skeleton but most commonly causes fractures in the spine and hip. Spinal or vertebral fractures also cause other serious side effects, with patients suffering from loss of height, deformity and persistent pain which can significantly impair mobility and quality of life. Fracture pain usually lasts 4 to 6 weeks, with intense pain at the fracture site. Chronic pain often occurs when one vertebral level is greatly collapsed or multiple levels are collapsed.
Postmenopausal women are predisposed to fractures, such as in the vertebrae, due to a decrease in bone mineral density that accompanies postmenopausal osteoporosis. Osteoporosis is a pathologic state that literally means “porous bones”. Skeletal bones are made up of a thick cortical shell and a strong inner meshwork, or cancellous bone, of collagen, calcium salts and other minerals. Cancellous bone is similar to a honeycomb, with blood vessels and bone marrow in the spaces. Osteoporosis describes a condition of decreased bone mass that leads to fragile bones which are at an increased risk for fractures. In an osteoporotic bone, the sponge-like cancellous bone has pores or voids that increase in dimension making the bone very fragile. In young, healthy bone tissue, bone breakdown occurs continually as the result of osteoclast activity, but the breakdown is balanced by new bone formation by osteoblasts. In an elderly patient, bone resorption can surpass bone formation thus resulting in deterioration of bone density. Osteoporosis occurs largely without symptoms until a fracture occurs.
Vertebroplasty and kyphoplasty are recently developed techniques for treating vertebral compression fractures. Percutaneous vertebroplasty was first reported by a French group in 1987 for the treatment of painful hemangiomas. In the 1990's, percutaneous vertebroplasty was extended to indications including osteoporotic vertebral compression fractures, traumatic compression fractures, and painful vertebral metastasis. Vertebroplasty is the percutaneous injection of PMMA (polymethylmethacrylate) into a fractured vertebral body via a trocar and cannula. The targeted vertebrae are identified under fluoroscopy. A needle is introduced into the vertebrae body under fluoroscopic control, to allow direct visualization. A bilateral transpedicular (through the pedicle of the vertebrae) approach is typical but the procedure can be done unilaterally. The bilateral transpedicular approach allows for more uniform PMMA infill of the vertebra.
In a bilateral approach, approximately 1 to 4 ml of PMMA is used on each side of the vertebra. Since the PMMA needs to be forced into the cancellous bone, the techniques require high pressures and fairly low viscosity cement. Since the cortical bone of the targeted vertebra may have a recent fracture, there is the potential of PMMA leakage. The PMMA cement contains radiopaque materials so that when injected under live fluoroscopy, cement localization and leakage can be observed. The visualization of PMMA injection and extravasation are critical to the technique—and the physician terminates PMMA injection when leakage is evident. The cement is injected using syringes to allow the physician manual control of injection pressure.
Kyphoplasty is a modification of percutaneous vertebroplasty. Kyphoplasty involves a preliminary step consisting of the percutaneous placement of an inflatable balloon tamp in the vertebral body. Inflation of the balloon creates a cavity in the bone prior to cement injection. The proponents of percutaneous kyphoplasty have suggested that high pressure balloon-tamp inflation can at least partially restore vertebral body height. In kyphoplasty, some physicians state that PMMA can be injected at a lower pressure into the collapsed vertebra since a cavity exists, when compared to conventional vertebroplasty.
The principal indications for any form of vertebroplasty are osteoporotic vertebral collapse with debilitating pain. Radiography and computed tomography must be performed in the days preceding treatment to determine the extent of vertebral collapse, the presence of epidural or foraminal stenosis caused by bone fragment retropulsion, the presence of cortical destruction or fracture and the visibility and degree of involvement of the pedicles.
Leakage of PMMA during vertebroplasty can result in very serious complications including compression of adjacent structures that necessitate emergency decompressive surgery. See “Anatomical and Pathological Considerations in Percutaneous Vertebroplasty and Kyphoplasty: A Reappraisal of the Vertebral Venous System”, Groen, R. et al, Spine Vol. 29, No. 13, pp 1465-1471 2004. Leakage or extravasation of PMMA is a critical issue and can be divided into paravertebral leakage, venous infiltration, epidural leakage and intradiscal leakage. The exothermic reaction of PMMA carries potential catastrophic consequences if thermal damage were to extend to the dural sac, cord, and nerve roots. Surgical evacuation of leaked cement in the spinal canal has been reported. It has been found that leakage of PMMA is related to various clinical factors such as the vertebral compression pattern, and the extent of the cortical fracture, bone mineral density, the interval from injury to operation, the amount of PMMA injected and the location of the injector tip. In one recent study, close to 50% of vertebroplasty cases resulted in leakage of PMMA from the vertebral bodies. See Hyun-Woo Do et al, “The Analysis of Polymethylmethacrylate Leakage after Vertebroplasty for Vertebral Body Compression Fractures”, Jour. of Korean Neurosurg. Soc. Vol. 35, No. 5 (May 2004) pp. 478-82, (http://www.jkns.or.kr/htm/abstract.asp?no=0042004086).
Another recent study was directed to the incidence of new VCFs adjacent to the vertebral bodies that were initially treated. Vertebroplasty patients often return with new pain caused by a new vertebral body fracture. Leakage of cement into an adjacent disc space during vertebroplasty increases the risk of a new fracture of adjacent vertebral bodies. See Am. J. Neuroradiol. 2004 February; 25(2):175-80. The study found that 58% of vertebral bodies adjacent to a disc with cement leakage fractured during the follow-up period compared with 12% of vertebral bodies adjacent to a disc without cement leakage.
Another life-threatening complication of vertebroplasty is pulmonary embolism. See Bernhard, J. et al, “Asymptomatic diffuse pulmonary embolism caused by acrylic cement: an unusual complication of percutaneous vertebroplasty”, Ann. Rheum. Dis. 2003; 62:85-86. The vapors from PMMA preparation and injection also are cause for concern. See Kirby, B, et al., “Acute bronchospasm due to exposure to polymethylmethacrylate vapors during percutaneous vertebroplasty”, Am. J. Roentgenol. 2003; 180:543-544.
In both higher pressure cement injection (vertebroplasty) and balloon-tamped cementing procedures (kyphoplasty), the methods do not provide for well controlled augmentation of vertebral body height. The direct injection of bone cement simply follows the path of least resistance within the fractured bone. The expansion of a balloon also applies to compacting forces along lines of least resistance in the collapsed cancellous bone. Thus, the reduction of a vertebral compression fracture is not optimized or controlled in high pressure balloons as forces of balloon expansion occur in multiple directions.
In a kyphoplasty procedure, the physician often uses very high pressures (e.g., up to 200 or 300 psi) to inflate the balloon which crushes and compacts cancellous bone. Expansion of the balloon under high pressures close to cortical bone can fracture the cortical bone, typically the endplates, which can cause regional damage to the cortical bone with the risk of cortical bone necrosis. Such cortical bone damage is highly undesirable as the endplate and adjacent structures provide nutrients for the disc.
Kyphoplasty also does not provide a distraction mechanism capable of 100% vertebral height restoration. Further, the kyphoplasty balloons under very high pressure typically apply forces to vertebral endplates within a central region of the cortical bone that may be weak, rather than distributing forces over the endplate.
There is a need for improved devices, systems and methods for use in the treatment of vertebral compression fractures.
In accordance with one embodiment, a method for treating bone is provided. The method comprises providing an elongated shaft capable of linear and curved shapes about a flex axis, and a shaft-associated cutting element that is adapted to assume a first configuration co-linear the shaft and flex axis and adapted to assume a second configuration that is not co-linear with the shaft and flex axis when the shaft is curved. The method also comprises positioning the shaft in cancellous bone in a curved shape and actuating the cutting element from the first configuration to the second configuration thereby creating a cut plane in the cancellous bone.
In accordance with another embodiment, a method for treating a vertebra is provided. The method comprises providing a shape memory shaft with a repose arc-shaped working end with a wire-like cutting element that is extendable away from the working end in a plane across the arc-shape. The method also comprises introducing the working end into cancellous bone in a vertebra, extending the cutting element away from the working end to thereby cut a plane in the cancellous bone, and introducing a bone cement flow into the plane in the cancellous bone.
In accordance with another embodiment, a method of treating a vertebra is provided. The method comprises providing a shaft having an arc-configurable working end with a wire-like cutting element that is extendable away from the working end in a plane across the arc-shape, introducing the working end into cancellous bone in a vertebra, causing the working end to extend at least about 90° in an arc configuration in the cancellous bone, and extending a cutting element from the working end across the arc configuration to thereby cut bone.
In accordance with still another embodiment, a device for treating bone is provided. The device comprises an elongated shaft capable of linear and curved shapes relative to an axis. The device also comprises an elongated cutting element carried by the shaft, the cutting element adapted to assume a first configuration co-linear the shaft and adapted to assume a second configuration that is not co-linear with the shaft when the shaft is curved.
In accordance with still another embodiment, a device for treating bone is provided. The device comprises an elongated shaft adapted for insertion through a cortical bone portion of a bone and into a cancellous bone portion of the bone, the elongated shaft having a linear shape extending along a longitudinal axis, at least a portion of the shaft being movable into a curved configuration within cancellous bone. The device also comprises a cutting element attached to said movable portion of the shaft, the cutting element moveable between a first configuration co-linear with the shaft and a second configuration away from the shaft with the movable portion of the shaft in the curved configuration to cut a plane in cancellous bone.
In accordance with still another embodiment, a device for treating bone is provided. The device comprises an elongated shaft adapted for insertion through a cortical bone portion of a bone and into a cancellous bone portion of the bone, the elongated shaft having a linear shape along a longitudinal axis, at least a portion of the shaft movable into a curved configuration within cancellous bone. The device also comprises a means for cutting a plane in cancellous bone, said means being attached to at least a portion of the elongated shaft.
In accordance with yet another embodiment, a method of treating bone is provided. The method comprises creating a path into a cancellous bone portion in a bone, inserting an elongated shaft along a longitudinal axis through said path into cancellous bone, the shaft having a cutting element attached to a working end of the shaft, moving the working end of the shaft into a curved configuration, and cutting a plane in cancellous bone with the cutting element.
In accordance with yet another embodiment, a kit for treating bone is provided. The kit comprises an injector configured for introduction into a bone, the injector configured to deliver bone cement through a channel thereof into the bone. The kit also comprises a cutting tool comprising an elongated shaft adapted for insertion through a cortical bone portion of the bone and into a cancellous bone portion of the bone, and a cutting element attached to said portion of the shaft, the cutting element moveable between a first configuration co-linear with the shaft and a second configuration not co-linear with the shaft to cut a plane in cancellous bone
These and other objects of the present embodiments of the invention will become readily apparent upon further review of the following drawings and specification.
In order to better understand the invention and to see how it may be carried out in practice, some preferred embodiments are next described, by way of non-limiting examples only, with reference to the accompanying drawings, in which like reference characters denote corresponding features consistent throughout similar embodiments in the attached drawings.
As background, a vertebroplasty procedure using any of the embodiments disclosed herein would include inserting the introducer of
“Bone fill, fill material, or infill material or composition” includes its ordinary meaning and is defined as any material for infilling a bone that includes an in-situ hardenable material or that can be infused with a hardenable material. The fill material also can include other “fillers” such as filaments, microspheres, powders, granular elements, flakes, chips, tubules and the like, autograft or allograft materials, as well as other chemicals, pharmacological agents or other bioactive agents.
“Flowable material” includes its ordinary meaning and is defined as a material continuum that is unable to withstand a static shear stress and responds with an irrecoverable flow (a fluid)—unlike an elastic material or elastomer that responds to shear stress with a recoverable deformation. Flowable material includes fill material or composites that include a fluid (first) component and an elastic or inelastic material (second) component that responds to stress with a flow, no matter the proportions of the first and second component, and wherein the above shear test does not apply to the second component alone.
“Substantially” or “substantial” mean largely but not entirely. For example, substantially may mean about 10% to about 99.999%, about 25% to about 99.999% or about 50% to about 99.999%.
“Osteoplasty” includes its ordinary meaning and means any procedure wherein fill material is delivered into the interior of a bone.
“Vertebroplasty” includes its ordinary meaning and means any procedure wherein fill material is delivered into the interior of a vertebra.
In
In one embodiment as shown in
As can be seen in
In one embodiment and method of use, referring to
In
Now referring to
In the system of
In one embodiment, as depicted in
The amorphous diamond-like carbon coatings and the diamond-like nanocomposites are available from Bekaert Progressive Composites Corporations, 2455 Ash Street, Vista, Calif. 92081 or its parent company or affiliates. Further information on the coating can be found at: http://www.bekaert.com/bac/Products/Diamond-like%20coatings.htm, the contents of which are incorporated herein by reference. The diamond-like coatings can be amorphous carbon-based coatings with high hardness and low coefficient of friction. The amorphous carbon coatings exhibit non-stick characteristics and excellent wear resistance. The coatings are thin, chemically inert and have a very low surface roughness. In one embodiment, the coatings have a thickness ranging between 0.001 mm and 0.010 mm; or between 0.002 mm and 0.005 mm. The diamond-like carbon coatings can be a composite of sp2 and sp3 bonded carbon atoms with a hydrogen concentration between 0 and 80%. Another diamond-like nanocomposite coatings (a-C:H/a-Si:O; DLN) is made by Bakaert and is suitable for use in the bone cement injectors disclosed herein. The materials and coatings are known by the names Dylyn®Plus, Dylyn®/DLC and Cavidur®.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination 125, wherein at least a portion of the surface layer 240 of the flow channel is ultrahydrophobic or hydrophobic which may better inhibit a hydrophilic cement from sticking.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination 125, wherein at least a portion of the surface layer 240 of the flow channel is hydrophilic, which may inhibit a hydrophobic cement from sticking.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination in a distal end thereof, wherein the surface layer 240 of the flow channel has high dielectric strength, a low dissipation factor, and/or a high surface resistivity.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination 125 in a distal end thereof, wherein the surface layer 240 of the flow channel is oleophobic.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination 125 in a distal end thereof, wherein the surface layer 240 of the flow channel has a substantially low coefficient of friction polymer or ceramic.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination 125 in a distal end thereof, wherein the surface layer 240 of the flow channel has a wetting contact angle greater than 70°, greater than 85°, and greater than 100°.
In another embodiment, the bone cement injector can have a flow channel 122 extending therethrough with at least one open termination in a distal end thereof, wherein the surface layer 240 of the flow channel has an adhesive energy of less than 100 dynes/cm, less than 75 dynes/cm, and less than 50 dynes/cm.
The apparatus above also can be configured with any other form of thermal energy emitter that includes the non-stick and/or lubricious surface layer as described above. In one embodiment, the thermal energy emitter can comprise at least in part an electrically conductive polymeric layer. In one such embodiment, the electrically conductive polymeric layer has a positive temperature coefficient of resistance.
Thus, as seen in
In another embodiment, the shaft can have first and second cutting elements (not shown) on opposing sides of the shaft. After positioning the shaft within a bone (e.g., with contemporaneous imaging), a distally-oriented cutting element can be extended outwardly from the shaft with the contemporaneous application of low frequency vibration, ultrasound energy delivery, oscillation, rotation or axial movement to cut cancellous bone, or any other energy delivery method.
In general, the method encompasses an actuating step that includes applying energy from the cutting element to body structure. The energy-applying step can includes applying energy selected from a group of thermal energy, ultrasound energy, vibration energy, mechanical energy, light energy, electromagnetic energy, radiofrequency energy, microwave energy, chemical energy, and other forms of energy delivery. The effect of such energy delivery is for cutting tissue, coagulating tissue, sealing tissue, damaging tissue, vaporizing tissue, and other methods of tissue manipulation.
In a further method of treating a bone, an additional step includes introducing bone fill material into the cut plane. The bone fill material is preferably a flowable material such as an exothermic bone cement.
The method can include creating a cut plane that is adapted to control and direct the flow of bone cement to provide lesser height dimension and greater lateral dimension to the cement volume. The cement volume thus can be planar or a pancake-like distribution rather than a “round” bolus.
In another method, a shaft having an arc-configurable working end can be introduced into cancellous bone in a vertebra, the working end can be positioned to extend at least about 90° in an arc configuration within the cancellous bone, and the cutting element can be actuated across the arc configuration to thereby cut bone. The method further includes causing the working end to extend in an arc of at least about 120°, 150°, 180°, 210° and 240°.
In another method of treating a bone, complementary shafts with two working ends can be introduced, one from each pedicle. The shaft working end can overlap or can connect at distal portions thereof. In another embodiment and method, a cutting wire can be passed from one working end to the other to allow an abrasive wire to move axially from one instrument to the other by actuation from handles thereof. In any such embodiment, an energy source can be coupled to the cutting element.
In another embodiment and method, a flexible or shape memory bone cement injector, such as the injector 105 described above, can be introduced into the path created by the shaft 400, and then cement can be injected from a plurality of ports along the length of the injector working end, wherein the ports are oriented toward the cut plane. The working end of the injector can have the heating element as described above, or preferably a polymeric PTCR heating element. In such an embodiment, the step of applying thermal energy can be accomplished by a resistive heating element that has a sleeve fabricated of a positive temperature coefficient of resistance (PTCR) material.
In another embodiment, the step applying thermal energy can be accomplished by light energy from an LED, or from at least one of coherent light and non-coherent light.
In another embodiment, the step of applying thermal energy can include the heat of vaporization from a vapor, which can be introduced through a channel in the injector to interact with the cement. Such a vapor can be generated from water, saline or any other biocompatible fluid.
An injection system, such as those disclosed above, can use any suitable energy source, other that radiofrequency energy, to accomplish the purpose of altering the viscosity of the fill material 145. The method of altering fill material can be at least one of a radiofrequency source, a laser source, a microwave source, a magnetic source, an ultrasound source, or any other energy source. Each of these energy sources can be configured to preferentially deliver energy to a cooperating, energy sensitive filler component carried by the fill material. For example, such filler can be suitable chromophores for cooperating with a light source, ferromagnetic materials for cooperating with magnetic inductive heating means, or fluids that thermally respond to microwave energy.
The scope of the invention includes, but is not limited to, using additional filler materials such as porous scaffold elements and materials for allowing or accelerating bone ingrowth. In any embodiment, the filler material can comprise reticulated or porous elements of the types disclosed in co-pending U.S. patent application Ser. No. 11/146,891, filed Jun. 7, 2005, titled “Implants and Methods for Treating Bone” which is incorporated herein by reference in its entirety and should be considered a part of this specification. Such fillers also can carry bioactive agents. Additional fillers, or the conductive filler, also can include thermally insulative solid or hollow microspheres of a glass or other material for reducing heat transfer to bone from the exothermic reaction in a typical bone cement component.
The above description of the some embodiments of the invention is intended to be illustrative and not exhaustive. Particular characteristics, features, dimensions and the like that are presented in dependent claims can be combined and fall within the scope of the invention. The invention also encompasses embodiments as if dependent claims were alternatively written in a multiple dependent claim format with reference to other independent claims. Specific characteristics and features of the invention and its method are described in relation to some figures and not in others, and this is for convenience only. While the principles of the invention have been made clear in the descriptions and combinations, it will be obvious to those skilled in the art that modifications may be utilized in the practice of the embodiments of the invention, and otherwise, which are particularly adapted to specific environments and operative requirements without departing from the principles of the invention. The appended claims are intended to cover and embrace any and all such modifications, with the limits only of the true purview, spirit and scope of the invention.
Certain embodiments disclosed herein provide vertebroplasty systems and methods for sensing retrograde bone cement flows that can migrate along a fractured path toward a pedicle and risk leakage into the spinal canal. The physician can be alerted instantaneously of cement migration in a direction that can impinge on nerves or the spinal cord. Other embodiments include integrated sensing systems and energy delivery systems for applying energy to tissue and/or to bone cement that migrates in a retrograde direction wherein the energy polymerizes the cement and/or coagulates tissue to create a dam to prevent further cement migration. In another embodiment, the systems provide a cooling system for cooling bone cement in a remote container or injection cannula for controlling and extending the working time of a bone cement. In another embodiment, the bone cement injection system includes a thermal energy emitter for warming a chilled bone cement in the distal end of an injector or for applying sufficient energy to accelerate polymerization and thereby increase the viscosity of the bone cement.
A computer controller can be provided to control cement inflow parameters from a hydraulic source, the sensing system and energy delivery parameters for selectively heating tissue or polymerizing cement at both the interior and exterior of the injector to thereby control all parameters of cement injection to reduce workload on the physician.
In one embodiment, a lubricous surface layer is provided in the flow passageway of the bone cement injector to prevent sticking particularly when heating the cement.
Of course, the foregoing description is that of certain features, aspects and advantages of the certain embodiments of the present invention, to which various changes and modifications can be made without departing from the spirit and scope of the present invention. Moreover, the bone treatment systems and methods need not feature all of the objects, advantages, features and aspects discussed above. Thus, for example, those skilled in the art will recognize that the invention can be embodied or carried out in a manner that achieves or optimizes one advantage or a group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein. In addition, while a number of variations of the invention have been shown and described in detail, other modifications and methods of use, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is contemplated that various combinations or subcombinations of these specific features and aspects of embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the discussed bone treatment systems and methods.
This application claims the benefit of U.S. Provisional Patent Application No. 60/851,682 filed Oct. 13, 2006, the entire contents of which are incorporated herein by reference and should be considered a part of this specification. This application is related to the following U.S. patent application Ser. No. 11/469,764 filed Sep. 1, 2006 titled Methods for Sensing Retrograde Flows of Bone Fill Material, Ser. No. 11/165,652 filed Jun. 24, 2005 titled Bone Treatment Systems and Methods; Ser. No. 60/726,152 (Docket No. S-7700-310) filed Oct. 13, 2005 titled Bone Treatment Systems and Methods; and Ser. No. 11/209,035 (Docket No. S-7700-280) filed Aug. 22, 2005, titled Bone Treatment Systems and Methods. The entire contents of all of the above applications are hereby incorporated by reference and should be considered a part of this specification.
Number | Date | Country | |
---|---|---|---|
60851682 | Oct 2006 | US |